Cargando…
EFFICACY AND SAFETY OF THERAPEUTIC VERSUS PROPHYLACTIC ANTICOAGULATION IN PATIENTS WITH COVID-19 INFECTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Autores principales: | FAIZAN, UNAIZA, ELKHAPERY, AHMED, JAIN, DEEPTANSHU, ANWER, FAIZ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548749/ http://dx.doi.org/10.1016/j.chest.2022.08.278 |
Ejemplares similares
-
INFECTIOUS COMPLICATIONS AFTER TOCILIZUMAB IN PATIENTS WITH COVID: A REAL-WORLD EXPERIENCE
por: LIU, HONGLI, et al.
Publicado: (2022) -
AORTIC THROMBUS DESPITE THERAPEUTIC DOSE OF ANTICOAGULATION IN A PATIENT POSITIVE FOR COVID-19
por: JACOME, VERONICA, et al.
Publicado: (2022) -
ACUTE MULTIPLE TERRITORIES STROKE IN AN ANTICOAGULATED COVID-19 PATIENT
por: BAWWAB, AMEED, et al.
Publicado: (2021) -
EFFECT OF ANTICOAGULATION AND ANTIPLATELET AGENTS ON HYPERCOAGULABILITY STATES IN PATIENTS WITH COVID-19
por: UR, JEANNIE, et al.
Publicado: (2021) -
DILEMMA OF SYSTEMIC ANTICOAGULATION: A COVID-19 PATIENT WITH SPONTANEOUS CHEST WALL HEMATOMA
por: Mechineni, Ashesha, et al.
Publicado: (2020)